Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients

BACKGROUND: Clopidogrel is an antiplatelet drug used in the treatment of ischemic stroke. Safety and efficacy of clopidogrel has been confirmed in CAPRIE, PRoFESS trials. However, these studies focused on patients aged less than 75 years. CYP2C19 polymorphisms resulted in individual differences in c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Neurol
Egile Nagusiak: Li, Changqing, Jia, Weihua, Li, Jian, Li, Fangfei, Ma, Jing, Zhou, Lichun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941922/
https://ncbi.nlm.nih.gov/pubmed/33685396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-021-02127-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak